Compare LSTR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSTR | GRFS |
|---|---|---|
| Founded | 1988 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.2B |
| IPO Year | 1994 | 2008 |
| Metric | LSTR | GRFS |
|---|---|---|
| Price | $166.26 | $7.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 2 |
| Target Price | ★ $187.69 | $10.87 |
| AVG Volume (30 Days) | 265.1K | ★ 459.9K |
| Earning Date | 10-27-2026 | 07-28-2022 |
| Dividend Yield | 1.04% | ★ 1.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $4,743,760,000.00 | N/A |
| Revenue This Year | $17.36 | $2.15 |
| Revenue Next Year | $10.96 | $6.22 |
| P/E Ratio | $146.37 | ★ $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $121.12 | $6.96 |
| 52 Week High | $228.46 | $9.90 |
| Indicator | LSTR | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 53.23 |
| Support Level | $164.41 | $7.33 |
| Resistance Level | $174.97 | $7.68 |
| Average True Range (ATR) | 3.75 | 0.15 |
| MACD | 0.27 | 0.03 |
| Stochastic Oscillator | 29.05 | 67.50 |
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.